How Does Cannabis THC Suppress Airway Collapse in Sleep Apnoea?
Posted
Updated
Author: Julia Sutton, MSc
Reviewed by: Dr. Clarissa Morton, PharmD
Researchers are studying how THC for airway collapse may offer a therapeutic pathway for sleep apnoea . Obstructive sleep apnoea is marked by repeated airway blockages at night, often due to reduced muscle tone in the throat. Evidence suggests that cannabinoids may influence both airway stability and respiratory drive.
The potential of THC for airway collapse relates to how it interacts with neurological and muscular pathways that control breathing. Studies have investigated whether its effects improve airway control without causing sedation.
Two major areas of focus provide insight into how this may work:
Airway Mechanics
Research on airway mechanics with THC shows it may stabilise airflow by reducing the collapse of throat muscles. This helps maintain oxygen flow during sleep.
Pharyngeal Tone
Cannabinoids may also improve pharyngeal tone with THC, strengthening upper airway muscles and reducing obstructions during apnoea events.
Neurological Control
By acting on the brainstem, THC may alter signals that influence airway reflexes, adding another protective mechanism.
Early findings suggest that THC for airway collapse has promise in improving airflow stability, with evidence linking it to better airway mechanics with THC and enhanced pharyngeal tone with THC. Larger trials are needed to confirm its role in treating sleep apnoea.
If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.
For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea.
Written by
Julia Sutton, MSc
Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.
All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.
Reviewed by
Dr. Clarissa Morton, PharmD
Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.
All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.
